Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chantelle Browne
Observed names:
Browne, Chantelle,
C Browne,
C. Browne
Institutions:
University Health Network,
Health Economics and Outcomes Research (United Kingdom)
Observed institutions:
University of Leeds,
University Health Network,
University of Auckland,
University of Alberta,
Bristol-Myers Squibb (United States),
Health Economics and Outcomes Research (United Kingdom),
Queen Elizabeth Hospital,
University of York,
Lancaster University
show all 9
OpenAlex ID:
A5072550764
Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
2016
·
Kamal Desai
, Swati B. Gupta
, et al.
·
BMC Infectious Diseases
·
175
PDF
Cost-effectiveness of silicone and alginate impressions for complete dentures
2014
·
C. Hulme
, G. Yu
, et al.
·
Journal of Dentistry
·
39
PDF
Estimating quality-adjusted life years from patient-reported visual functioning
2012
·
C Browne
, J Brazier
, et al.
·
Eye
·
38
PDF
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence
2016
·
Tereza Lanitis
, Robert Leipold
, et al.
·
Clinical Therapeutics
·
26
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
2018
·
Louis Matza
, Kristina Boye
, et al.
·
Patient Preference and Adherence
·
20
PDF
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
2017
·
Tereza Lanitis
, Robert Leipold
, et al.
·
BMC Health Services Research
·
16
PDF
Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from EORTC QLQ Data in Myeloma for Use in Cost-Effectiveness Analysis
2015
·
Samer A. Kharroubi
, Richard Edlin
, et al.
·
Medical Decision Making
·
16
Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin
2016
·
Chantelle Browne
, Noemi Muszbek
, et al.
·
International Journal of Antimicrobial Agents
·
10
Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France
2023
·
Lauren Brown
, Kelly J Sutton
, et al.
·
European Journal of Public Health
·
6
PDF
Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism
2014
·
T. Lanitis
, M. Hamilton
, et al.
·
Value in Health
·
6
Selected Enteropathogens and Clinical Course in Children Hospitalized with Severe Acute Gastroenteritis in Barbados
2014
·
Alok Kumar
, Chantelle Browne
, et al.
·
International Journal of Health Sciences
·
5
Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism
2016
·
C. Browne
, T. Lanitis
, et al.
·
Journal of Medical Economics
·
3
PDF
Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism
2015
·
T Lanitis
, M Hamilton
, et al.
·
Value in Health
·
3
Patient Preferences In Italy: Health State Utilities Associated With Attributes Of Weekly Injection Devices For Treatment Of Type 2 Diabetes
2017
·
LS Matza
, KS Boye
, et al.
·
Value in Health
·
2
PDF
Using Daptomycin in Hospitalised Patients with cSSTI Caused by Staphylococcus aureus Has an Impact on Costs
2013
·
Noemi Muszbek
, Ruth Chapman
, et al.
·
Chemotherapy
·
1
Determining cost-effectiveness of advanced cancer care: a systematic review of economic models
2011
·
C Hulme
, C Browne
, et al.
·
BMJ Supportive & Palliative Care
·
1
Intraprofessional collaboration in acute care: Generating evidence to inform nursing workforce retention strategies
2026
·
Alyssa Indar
, Sherry Espin
, et al.
·
Nursing Outlook
Wcn26-6513 Demonstrating the Link Between Treatment Adherence and Superior Outcomes in Patients With Ckd
2026
·
James Weatherall
, Chantelle Browne
, et al.
·
Kidney International Reports
Clinical Events Avoided with Apixaban Compared to Edoxaban for the Initial Treatment and Prevention of Venous Thromboembolism
2016
·
T Lanitis
, M Hamilton
, et al.
·
Value in Health
Validation of the Apixaban Cost-effectiveness Model in Patients With Venous Thromboembolism
2015
·
Tereza Lanitis
, Melissa Hamilton
, et al.
·
Journal of the American College of Cardiology
PDF
Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies
2014
·
D.M. Meads
, C. McCabe
, et al.
·
Value in Health
PDF
Lifetime Clinical Events Avoided And Resource Utilization With Apixaban Compared To Low-Molecular-Weight Heparin Followed By A Vitamin K Antagonist For The Treatment And Prevention Of Venous Thromboembolism
2014
·
M. Hamilton
, H. Phatak
, et al.
·
Value in Health
Generating utility values for use in cost-utility analyses of delirium interventions
2013
·
D.M. Meads
, C. Browne
, et al.
·
Value in Health
PDF
Generating an economic model to estimate the cost-effectiveness of a delirium prevention intervention for elderly hospitalised patients
2013
·
C.T. Hulme
, J. Willson
, et al.
·
Value in Health
Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis
2013
·
Samer Kharroubi
, Richard Edlin
, et al.
·
RePEc: Research Papers in Economics
Show more works
View as search
Works count:
37
Citation count:
367
H-index:
8
I10-index:
8
Year
Topic
Type